Background
The Clinical and Functional Translation of CFTR project (CFTR2) classified some cystic fibrosis transmembrane conductance regulator (CFTR) gene variants as non cystic fibrosis (CF)-causing. To evaluate this, the clinical status of children carrying these mutations was examined.
Methods
We analyzed CF disease-defining variables over 2–6 years in two groups of California CF screen- positive neonates born from 2007–2011: (1) children with two CF-causing variants and (2) children with one CF-causing and one non-CF causing variant, as defined by CFTR2.
Results
Children carrying non CF-causing variants had significantly higher birth weight, lower immunoreactive trypsinogen and sweat chloride values, higher first year growth curves, and a lower rate of persistent Pseudomonas aeruginosa colonization compared to children with two CF-causing variants.
Conclusions
The outcomes in children 2–6 years of age with the L997F, G576A, R1162L, V754M, R668C, R31C, and S1235R variants are consistent with the CFTR2 non CF-causing classification.